木林森(002745.SZ)下屬子公司近日收到政府補貼4000萬元
格隆匯 1 月 3日丨木林森(002745.SZ)公佈,根據中共吉安市委辦公室、吉安市人民政府辦公室印發《關於推進首位產業龍頭企業發展的若干意見》(吉辦發【2017】4號)與井岡山經濟技術開發區管理委會下發的《井岡山經開區關於支持“1+3”產業發展的暫行辦法》(井開字【2017】42號)的規定,公司下屬子公司吉安市木林森實業有限公司於近日收到政府補貼4000萬元,上述資金2020年12月31日已劃撥至吉安市木林森實業有限公司的賬户,系與收益相關的政府補助,於收到時確認為當期收益。該政府補助資金,不具有可持續性。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.